참고문헌 (44)

1. 1. Boyle W.J. Simonet W.S. Lacey D.L. Osteoclast differentiation and activation Nature 2003 423 337 342 10.1038/nature01658 12748652 

   상세보기

2. 2. Lacey D.L. Timms E. Tan H.L. Kelley M.J. Dunstan C.R. Burgess T. Elliott R. Colombero A. Elliott G. Scully S. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 1998 93 165 176 10.1016/S0092-8674(00)81569-X 9568710 

   상세보기

3. 3. Kong Y.Y. Yoshida H. Sarosi I. Tan H.L. Timms E. Capparelli C. Morony S. Oliveira-dos-Santos A.J. Van G. Itie A. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 1999 397 315 323 10.1038/16852 9950424 

   상세보기

4. 4. Gohda J. Akiyama T. Koga T. Takayanagi H. Tanaka S. Inoue J. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis EMBO J. 2005 24 790 799 10.1038/sj.emboj.7600564 15678102 

   상세보기

5. 5. Yamashita T. Yao Z. Li F. Zhang Q. Badell I.R. Schwarz E.M. Takeshita S. Wagner E.F. Noda M. Matsuo K. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 J. Biol. Chem. 2007 282 18245 18253 10.1074/jbc.M610701200 17485464 

   상세보기

6. 6. Takayanagi H. Kim S. Koga T. Nishina H. Isshiki M. Yoshida H. Saiura A. Isobe M. Yokochi T. Inoue J. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell 2002 3 889 901 10.1016/S1534-5807(02)00369-6 12479813 

   상세보기

7. 7. Huang H. Chang E.J. Ryu J. Lee Z.H. Lee Y. Kim H.H. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway Biochem. Biophys. Res. Commun. 2006 351 99 105 10.1016/j.bbrc.2006.10.011 17052691 

   상세보기

8. 8. Lee J.H. Jin H. Shim H.E. Kim H.N. Ha H. Lee Z.H. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal Mol. Pharmacol. 2010 77 17 25 10.1124/mol.109.057877 19828731 

   상세보기

9. 9. Ikeda F. Nishimura R. Matsubara T. Tanaka S. Inoue J. Reddy S.V. Hata K. Yamashita K. Hiraga T. Watanabe T. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation J. Clin. Invest. 2004 114 475 484 10.1172/JCI200419657 15314684 

   상세보기

10. 10. Sato K. Suematsu A. Nakashima T. Takemoto-Kimura S. Aoki K. Morishita Y. Asahara H. Ohya K. Yamaguchi A. Takai T. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway Nat. Med. 2006 12 1410 1416 17128269 

    상세보기

11. 11. Tanaka S. Nakamura K. Takahasi N. Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system Immunol. Rev. 2005 208 30 49 16313339 

    상세보기

12. 12. Banu J. Varela E. Fernandes G. Alternative therapies for the prevention and treatment of osteoporosis Nutr. Rev. 2012 70 22 40 10.1111/j.1753-4887.2011.00451.x 22221214 

    상세보기

13. 13. Putnam S.E. Scutt A.M. Bicknell K. Priestley C.M. Williamson E.M. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health Phytother. Res. 2007 21 99 112 10.1002/ptr.2030 17106868 

    상세보기

14. 14. Yu T. Lee J. Lee Y.G. Byeon S.E. Kim M.H. Sohn E.H. Lee Y.J. Lee S.G. Cho J.Y. In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum J. Ethnopharmacol. 2010 128 139 147 10.1016/j.jep.2009.12.042 20045722 

    상세보기

15. 15. Liu Q. Shin E. Ahn M.J. Hwang B.Y. Lee M.K. Anti-adipogenic activity of Acer tegmentosum and its constituent, catechin in 3T3-L1 cells Nat. Prod. Sci. 2011 17 212 215 

16. 16. Kim S. Hur S.H. Kim K.H. Kim S.G. Whang W.K. Antioxidant and anti-inflammatory compounds isolated from Acer tegmentosum J. Med. Plants Res. 2012 6 3971 3976 

17. 17. Lee S. Woo H. A study of the inhibitory effect of Acer tegmentosum Max. on fibrogenesis in hepatic stellate cell line T6 Korean J. Orient. Int. Med. 2010 31 346 355 

18. 18. Yoo Y.M. Nam J.H. Kim M.Y. Choi J. Lee K.T. Park H.J. Analgesic and anti-gastropathic effects of salidroside Isolated from Acer tegmentosum heartwood Open Bioact. Compound. J. 2009 2 1 7 10.2174/1874847300902010001 

    상세보기

19. 19. Tung N.H. Ding Y. Kim S.K. Bae K. Kim Y.H. Total peroxyl radical-scavenging capacity of the chemical components from the stems of Acer tegmentosum maxim J. Agric. Food Chem. 2008 56 10510 10514 10.1021/jf8020283 18942844 

    상세보기

20. 20. Park K.M. Yang M.C. Lee K.H. Kim K.R. Choi S.U. Lee K.R. Cytotoxic phenolic constituents of Acer tegmentosum maxim Arch. Pharm. Res. 2006 29 1086 1090 10.1007/BF02969296 17225455 

    원문보기 상세보기

21. 21. Hwang Y.H. Park H. Ma J.Y. In vitro and in vivo safety evaluation of Acer tegmentosum J. Ethnopharmacol. 2013 148 99 105 10.1016/j.jep.2013.03.074 23602732 

    상세보기

22. 22. Wu Y.L. Lian L.H. Jiang Y.Z. Nan J.X. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice J. Pharm. Pharmacol. 2009 61 1375 1382 10.1211/jpp.61.10.0015 19814871 

    상세보기

23. 23. Li D. Fu Y. Zhang W. Su G. Liu B. Guo M. Li F. Liang D. Liu Z. Zhang X. Salidroside attenuates inflammatory responses by suppressing nuclear factor-kappaB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice Inflamm. Res. 2013 62 9 15 10.1007/s00011-012-0545-4 22915087 

    상세보기

24. 24. Zhang L. Yu H. Sun Y. Lin X. Chen B. Tan C. Cao G. Wang Z. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells Eur. J. Pharmacol. 2007 564 18 25 17349619 

    상세보기

25. 25. Zhang B.C. Li W.M. Guo R. Xu Y.W. Salidroside decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice Evid. Based Complement. Alternat. Med. 2012 2012 607508 23093983 

    상세보기

26. 26. Sheng Q.S. Wang Z.J. Zhang J. Zhang Y.G. Salidroside promotes peripheral nerve regeneration following crush injury to the sciatic nerve in rats Neuroreport 2013 24 217 223 10.1097/WNR.0b013e32835eb867 23358450 

    상세보기

27. 27. Chen J.J. Zhang N.F. Mao G.X. He X.B. Zhan Y.C. Deng H.B. Song D.Q. Li D.D. Li Z.R. Si S.Y. Salidroside stimulates osteoblast differentiation through BMP signaling pathway Food Chem. Toxicol. 2013 62 499 505 10.1016/j.fct.2013.09.019 24055767 

    상세보기

28. 28. Zhang J.K. Yang L. Meng G.L. Yuan Z. Fan J. Li D. Chen J.Z. Shi T.Y. Hu H.M. Wei B.Y. Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators PLoS One 2013 8 e57251 23437352 

    상세보기

29. 29. Matsuo K. Galson D.L. Zhao C. Peng L. Laplace C. Wang K.Z. Bachler M.A. Amano H. Aburatani H. Ishikawa H. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos J. Biol. Chem. 2004 279 26475 26480 10.1074/jbc.M313973200 15073183 

    상세보기

30. 30. Kim H.J. Lee Y. Chang E.J. Kim H.M. Hong S.P. Lee Z.H. Ryu J. Kim H.H. Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: A sphingosine kinase inhibition-independent action Mol. Pharmacol. 2007 72 418 428 10.1124/mol.107.034173 17504945 

    상세보기

31. 31. Iotsova V. Caamano J. Loy J. Yang Y. Lewin A. Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2 Nat. Med. 1997 3 1285 1289 10.1038/nm1197-1285 9359707 

    상세보기

32. 32. Hayden M.S. Ghosh S. NF-kappaB, the first quarter-century: Remarkable progress and outstanding questions Genes Dev. 2012 26 203 234 10.1101/gad.183434.111 22302935 

    상세보기

33. 33. Jimi E. Aoki K. Saito H. D'Acquisto F. May M.J. Nakamura I. Sudo T. Kojima T. Okamoto F. Fukushima H. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo Nat. Med. 2004 10 617 624 15156202 

34. 34. Dai S. Hirayama T. Abbas S. Abu-Amer Y. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis J. Biol. Chem. 2004 279 37219 37222 15252035 

    상세보기

35. 35. Ruocco M.G. Maeda S. Park J.M. Lawrence T. Hsu L.C. Cao Y. Schett G. Wagner E.F. Karin M. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss J. Exp. Med. 2005 201 1677 1687 10.1084/jem.20042081 15897281 

    상세보기

36. 36. Yang F. Tang E. Guan K. Wang C.Y. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide J. Immunol. 2003 170 5630 5635 12759443 

    상세보기

37. 37. Doyle S.L. Jefferies C.A. O'Neill L.A. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide J. Biol. Chem. 2005 280 23496 23501 10.1074/jbc.C500053200 15849198 

    상세보기

38. 38. Sasaki C.Y. Barberi T.J. Ghosh P. Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway J. Biol. Chem. 2005 280 34538 34547 10.1074/jbc.M504943200 16105840 

    상세보기

39. 39. Huang H. Ryu J. Ha J. Chang E.J. Kim H.J. Kim H.M. Kitamura T. Lee Z.H. Kim H.H. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL Cell Death Differ. 2006 13 1879 1891 10.1038/sj.cdd.4401882 16498455 

    상세보기

40. 40. Tomimori Y. Mori K. Koide M. Nakamichi Y. Ninomiya T. Udagawa N. Yasuda H. Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss J. Bone Miner. Res. 2009 24 1194 1205 10.1359/jbmr.090217 19257825 

    상세보기

41. 41. Naylor K. Eastell R. Bone turnover markers: Use in osteoporosis Nat. Rev. Rheumatol. 2012 8 379 389 10.1038/nrrheum.2012.86 22664836 

    상세보기

42. 42. Ha H. An H. Shim K.S. Kim T. Lee K.J. Hwang Y.H. Ma J.Y. Ethanol extract of Atractylodes macrocephala protects bone loss by inhibiting osteoclast differentiation Molecules 2013 18 7376 7388 10.3390/molecules18077376 23884114 

    상세보기

43. 43. Lee J.H. Kim H.N. Yang D. Jung K. Kim H.M. Kim H.H. Ha H. Lee Z.H. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling J. Biol. Chem. 2009 284 13725 13734 10.1074/jbc.M806941200 19299513 

    상세보기

44. 44. Janckila A.J. Takahashi K. Sun S.Z. Yam L.T. Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b J. Bone Miner. Res. 2001 16 788 793 10.1359/jbmr.2001.16.4.788 11316008 

    상세보기